Novus Biologicals™ cIAP-1/HIAP-2 Antibody Blocking Peptide

Catalog No.	Quantity
NBP177193E	0.05 mg

Catalog No. NBP177193E Supplier Novus Biologicals™ Supplier No. NBP177193PEP

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide containing 14 amino acids near the carboxy terminus of human cIAP1. Source: Synthetic (Accession #: NP_001157) The cIAP-1/HIAP-2 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

• Gene ID (Entrez): 329
• Species: Human
• Accession Number: Q13490
• Content And Storage: Store at -20 C. Avoid freeze-thaw cycles.
• Formulation: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• For Use With (Application): This Peptide is Useful as a Blocking Peptide for NBP1-77193. For Further Blocking Peptide Related Protocol, Click Here .
• Gene Alias: API1Hiap-2, apoptosis inhibitor 1, baculoviral IAP repeat containing 2, baculoviral IAP repeat-containing 2, baculoviral IAP repeat-containing protein 2, cIAP1, C-IAP1, hIAP2, hIAP-2, IAP homolog B, IAP2, IAP-2, Inhibitor of apoptosis protein 2, MIHBHIAP2, NFR2-TRAF signalling complex protein, RING finger protein 48, RNF48hiap-2, TNFR2-TRAF-signaling complex protein 2
• Gene Symbol: BIRC2
• Product Type: cIAP-1/HIAP-2
• Quantity: 0.05 mg
• Regulatory Status: RUO - research use only
• Source: Synthetic
• Termination: 14 amino acids near the carboxy terminus of human cIAP1